IU Health Arnett Clinical Research

Clinical research is crucial to the development of new treatments and new uses for current medications. Clinical research studies, or trials, test investigational drugs or devices to determine efficacy.

Treating participants with respect and dignity, while placing their safety as top priority during a clinical trial are of the utmost importance to IU Health Arnett Clinical Research.

IU Health Arnett Clinical Research has conducted clinical trials in Lafayette, Indiana since 1990. Vijaya Kakani, MD is the medical director of clinical research at IU Health Arnett. Dr. Kakani is Board Certified in Medical Oncology. At IU Health Arnett Clinical Research, we are indeed Testing Today for the Treatments of Tomorrow.

Overview

Clinical research is crucial to the development of new treatments and new uses for current medications. Clinical research studies, or trials, test investigational drugs or devices to determine efficacy.

Treating participants with respect and dignity, while placing their safety as top priority during a clinical trial are of the utmost importance to IU Health Arnett Clinical Research.

IU Health Arnett Clinical Research has conducted clinical trials in Lafayette, Indiana since 1990. Vijaya Kakani, MD is the medical director of clinical research at IU Health Arnett. Dr. Kakani is Board Certified in Medical Oncology. At IU Health Arnett Clinical Research, we are indeed Testing Today for the Treatments of Tomorrow.

Treatment/ Interventional Trials

Breast Cancer

IUSCC-J13104: A randomized Phase II Study of Partial Breast Irradiation and Sequential vs. Concurrent Chemotherapy in Women with Early Stage Breast Cancer

Cancers

Cancers: LOXO-BTK-20020: A Phase 3 Open-label, Randomized Study of LOXO-305 versus Investigator’s Choice of Idelalisib plus Rituximab or Bendamustine plus Rituximab in BTK Inhibitor Pretreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (BRUIN CLL-321)

Lung Cancer

Mirati 516-005: A Randomized Phase 3 Study of Sitravatinib in Combination with Nivolumab Versus Docetaxel in Patients with Advanced Non-squamous Non-Small Cell Lung Cancer with Disease Progression On or After Platinum-Based Chemotherapy in Combination with Checkpoint Inhibitor Therapy

Non-Treatment/Observational/Blood Sample Collection Trials

Breast Cancer

Dx Biosamples DxB-149: Collection of fresh blood from metastatic Breast Cancer patients (stage IV)

Cancers

Dx Biosamples DxB-175: Collection of fresh blood from any stage cancers listed. Colorectal Cancer, Non-Small Cell Lung Cancer, Breast Cancer, Ovarian Cancer, Prostate Cancer

Current Trials

Treatment/ Interventional Trials

Breast Cancer

IUSCC-J13104: A randomized Phase II Study of Partial Breast Irradiation and Sequential vs. Concurrent Chemotherapy in Women with Early Stage Breast Cancer

Cancers

Cancers: LOXO-BTK-20020: A Phase 3 Open-label, Randomized Study of LOXO-305 versus Investigator’s Choice of Idelalisib plus Rituximab or Bendamustine plus Rituximab in BTK Inhibitor Pretreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (BRUIN CLL-321)

Lung Cancer

Mirati 516-005: A Randomized Phase 3 Study of Sitravatinib in Combination with Nivolumab Versus Docetaxel in Patients with Advanced Non-squamous Non-Small Cell Lung Cancer with Disease Progression On or After Platinum-Based Chemotherapy in Combination with Checkpoint Inhibitor Therapy

Non-Treatment/Observational/Blood Sample Collection Trials

Breast Cancer

Dx Biosamples DxB-149: Collection of fresh blood from metastatic Breast Cancer patients (stage IV)

Cancers

Dx Biosamples DxB-175: Collection of fresh blood from any stage cancers listed. Colorectal Cancer, Non-Small Cell Lung Cancer, Breast Cancer, Ovarian Cancer, Prostate Cancer

For more information about IU Health Arnett oncology/hematology clinical trials, or if you would like to participate, please contact:

Julia Keenoy, CCRP
Sr. Clinical Research Coordinator - Team Lead
Indiana University Health Arnett Cancer Center
Email

Zonda Bryant, MS
Coordinator
Clinical Research
Phone: 765.838.6871
Fax: 765.448.7599
Email

Celine Withers, RPh BCOP
Administrative Director
Indiana University Health Arnett Cancer Center
Phone: 765.838.7312
Fax: 765.448.7599
Email

Contact

For more information about IU Health Arnett oncology/hematology clinical trials, or if you would like to participate, please contact:

Julia Keenoy, CCRP
Sr. Clinical Research Coordinator - Team Lead
Indiana University Health Arnett Cancer Center
Email

Zonda Bryant, MS
Coordinator
Clinical Research
Phone: 765.838.6871
Fax: 765.448.7599
Email

Celine Withers, RPh BCOP
Administrative Director
Indiana University Health Arnett Cancer Center
Phone: 765.838.7312
Fax: 765.448.7599
Email